Bruce Carter
Chairman presso ENANTA PHARMACEUTICALS, INC.
Patrimonio netto: - $ in data 31/03/2024
Profilo
Bruce Leonard Andrews Carter is currently the Non-Executive Chairman at Enanta Pharmaceuticals, Inc. He is also the Chairman at ALSP Orchid Acquisition Corp.
I, Director at Dr. Reddy's Laboratories, Inc., Independent Director at Aurigene Discovery Technologies Ltd., Professor at the University of Washington, and Senior Advisor at Accelerator Services Corp.
In the past, Dr. Carter served as Chairman at ZymoGenetics, Inc. from 2009 to 2010.
He was also the Executive Chairman at Global Alliance for TB Drug Development in 2013, Chairman at Xencor, Inc. from 2009 to 2017, Executive Chairman at Immune Design Corp.
from 2009 to 2011, Executive Chairman at Infectious Disease Research Institute in 2009, Chairman at Infectious Disease Research Institute, Independent Director at QLT, Inc. from 2006 to 2012, Independent Non-Executive Director at Dr. Reddy's Laboratories Ltd.
from 2008 to 2022, Director at Renovis, Inc. from 2005 to 2008, Director at McAdams Wright Ragen, Inc., Director at Biothera, Inc., Director at moksha8 Pharmaceuticals, Inc., Non-Executive Director at Ark Therapeutics Group Plc, Independent Director at Mirati Therapeutics, Inc. from 2016 to 2024, and Independent Director at Regulus Therapeutics, Inc. from 2012 to 2015.
He also served as Director at Immune Design Corp.
from 2000 to 2009 and Navigating Cancer, Inc., Chief Scientific Officer & Executive VP at Novo Nordisk A from 1994 to 1998, and Head-Molecular Genetics at G.D.
Searle & Co., Inc. from 1982 to 1986.
Dr. Carter obtained a doctorate degree from Queen Elizabeth College and an undergraduate degree from The University of Nottingham.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 06/03/2024 | 0 ( -.--% ) | - $ | 31/03/2024 |
Posizioni attive di Bruce Carter
| Società | Posizione | Inizio |
|---|---|---|
| ENANTA PHARMACEUTICALS, INC. | Chairman | 14/12/2015 |
| ALSP ORCHID ACQUISITION CORPORATION I | Chairman | - |
Dr. Reddy's Laboratories, Inc.
 Dr. Reddy's Laboratories, Inc. Medical/Nursing ServicesHealth Services Dr. Reddy's Laboratories, Inc. develops pharmaceutical products. It also provides research and development activities and other medical testing services. The company is headquartered in Charlotte, NC. | Director/Board Member | - |
Aurigene Discovery Technologies Ltd.
 Aurigene Discovery Technologies Ltd. BiotechnologyHealth Technology Aurigene Discovery Technologies Ltd. operates as biotechnology company. It offers research services such as integrated research and stand-alone research. The company is headquartered in Bangalore, India. | Director/Board Member | - |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | Corporate Officer/Principal | 01/01/1986 |
Accelerator Services Corp
 Accelerator Services Corp Investment ManagersFinance Accelerator Services Corp (Accelerator Services) is a venture capital firm founded in 2003 by Carl Weissman and Rodney F. Burgar. The firm is headquartered in Seattle, Washington. | Consultant / Advisor | - |
Precedenti posizioni note di Bruce Carter
| Società | Posizione | Fine |
|---|---|---|
| MIRATI THERAPEUTICS | Director/Board Member | 23/01/2024 |
Global Alliance for TB Drug Development
 Global Alliance for TB Drug Development Pharmaceuticals: GenericHealth Technology Global Alliance for TB Drug Development operates as a not-for-profit organization dedicated to the discovery and development of tuberculosis drugs. It builds partnerships between the public, private, academic, and philanthropic sectors to drive the development of new products for underserved markets. The company was founded in February 2000 and is headquartered in New York , NY. | Chairman | 23/02/2023 |
| DR. REDDY'S LABORATORIES LIMITED | Director/Board Member | 30/07/2022 |
| ░░░░░░░ ░░░░ | ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Formazione di Bruce Carter
| Queen Elizabeth College | Doctorate Degree |
| The University of Nottingham | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 5 |
|---|---|
| DR. REDDY'S LABORATORIES LIMITED | Health Technology |
| NOVO NORDISK A/S | Health Technology |
| XENCOR, INC. | Health Technology |
| ENANTA PHARMACEUTICALS, INC. | Health Technology |
| REGULUS THERAPEUTICS INC. | Health Technology |
| Aziende private | 17 |
|---|---|
QLT, Inc.
 QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | Commercial Services |
ZymoGenetics, Inc.
 ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA. | Health Technology |
Renovis, Inc.
 Renovis, Inc. Pharmaceuticals: MajorHealth Technology Renovis, Inc. develops pharmaceutical products. The company discovers, develops, and commercializes novel therapeutics for neurological and inflammatory diseases. It is headquartered in San Francisco, CA | Health Technology |
McAdams Wright Ragen, Inc.
 McAdams Wright Ragen, Inc. Investment Banks/BrokersFinance Founded in 1999, McAdams Wright Ragen, Inc. (MWR) is a an SEC-registered investment advisor and broker/dealer located in Seattle, Washington. In July 2014, the firm was acquired by Baird Financial Corp., which is, in turn, owned by Baird Holding Co., which is owned by Baird Financial Group, Inc. MWR is comprised of a retail brokerage, an investment advisor, an institutional sales department, a research staff, a bond department and an agency stock trading desk. They offer am array of products and services for retail and institutional investors. Their research is based on the fundamentals. In assessing the merits of potential investments, their analysts provide analyses of management, earnings, growth potential, assets and other fundamental factors that influence the price of a security. MWR focuses on a broad spectrum of industries, geographies and investment styles. | Finance |
Biothera, Inc.
 Biothera, Inc. Miscellaneous Commercial ServicesCommercial Services Biothera, Inc. develops natural gluco polysaccharide that engages and directs natural innate immune systems. The company was founded by Daniel Conners in 1997 and is headquartered in Eagan, MN. | Commercial Services |
Global Alliance for TB Drug Development
Global Alliance for TB Drug Development Pharmaceuticals: GenericHealth Technology Global Alliance for TB Drug Development operates as a not-for-profit organization dedicated to the discovery and development of tuberculosis drugs. It builds partnerships between the public, private, academic, and philanthropic sectors to drive the development of new products for underserved markets. The company was founded in February 2000 and is headquartered in New York , NY. | Health Technology |
moksha8 Pharmaceuticals, Inc.
 moksha8 Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology moksha8 Pharmaceuticals, Inc. operates as a pharmaceutical company. It's products include viibryd, razapina, queopine, benexafrina, arasid, ziledon, zopina, and rispalum. The firm offers a portfolio of therapeutics for bipolar disorders and schizophrenia. The company was founded by Balkrishan Gill in 2007 and is headquartered in Berwyn, PA. | Health Technology |
G.D. Searle & Co., Inc.
 G.D. Searle & Co., Inc. Chemicals: SpecialtyProcess Industries G.D. Searle & Co., Inc. is a company that produces a diverse range of chemicals and agricultural products. The company is based in St. Louis, MO. G.D. Searle & Co. was acquired by Monsanto Co. /Old/ on January 01, 1985. | Process Industries |
Ark Therapeutics Group Plc
 Ark Therapeutics Group Plc Miscellaneous Commercial ServicesCommercial Services Ark Therapeutics Group Plc is a gene-based medicine company, which is engaged in the discovery, development and commercialization of products in areas of specialist medicine, with particular focus on vascular disease and cancer. The company was founded by Peter Stephen Keen, John W. Martin, Seppo Ylä-Herttuala, Stephen Barker and Kenneth Powell in July 1997 and is headquartered in London, the United Kingdom. | Commercial Services |
Mirati Therapeutics, Inc.
 Mirati Therapeutics, Inc. BiotechnologyHealth Technology Mirati Therapeutics, Inc. operates as a clinical-stage oncology company. engages in the development of novel therapeutics. The firm's products target the genetic and immunological promoters of cancer. Its clinical pipeline consists of Adagrasib, MRTX1133, and Sitravatinib. The company was founded on December 13, 1995, and is headquartered in San Diego, CA. | Health Technology |
Accelerator Services Corp
Accelerator Services Corp Investment ManagersFinance Accelerator Services Corp (Accelerator Services) is a venture capital firm founded in 2003 by Carl Weissman and Rodney F. Burgar. The firm is headquartered in Seattle, Washington. | Finance |
Dr. Reddy's Laboratories, Inc.
Dr. Reddy's Laboratories, Inc. Medical/Nursing ServicesHealth Services Dr. Reddy's Laboratories, Inc. develops pharmaceutical products. It also provides research and development activities and other medical testing services. The company is headquartered in Charlotte, NC. | Health Services |
Immune Design Corp.
 Immune Design Corp. Pharmaceuticals: MajorHealth Technology Immune Design Corp. is a clinical-stage immunotherapy company focused on cancer with in vivo approaches designed to enable the body's immune system to fight disease. It develops multiple product candidates from its discovery platforms, ZVex and GLAAS. The company was founded by Steven G. Reed and David Baltimore on February 20, 2008 and is headquartered in Kenilworth, NJ. | Health Technology |
Infectious Disease Research Institute
 Infectious Disease Research Institute Miscellaneous Commercial ServicesCommercial Services Infectious Disease Research Institute operates as a innovative science to research and development company. It offers pipeline, adjuvants, vaccines, diagnostics and drugs products. The firm also provides manufacturing, analytical methods, stability studies, process and contact services. The company was founded by Steven G. Reed in 1993 and is headquartered in Seattle, WA. | Commercial Services |
Aurigene Discovery Technologies Ltd.
Aurigene Discovery Technologies Ltd. BiotechnologyHealth Technology Aurigene Discovery Technologies Ltd. operates as biotechnology company. It offers research services such as integrated research and stand-alone research. The company is headquartered in Bangalore, India. | Health Technology |
Navigating Cancer, Inc.
 Navigating Cancer, Inc. Medical/Nursing ServicesHealth Services Navigating Cancer, Inc. develops patient relationship management software for cancer care. It offers care management, population health, patient portal and other consulting services. The firm’s products combine clinical workflows, oncology content, and data insights to personalized patient care for cancer patients inside and outside of the clinic. The company was founded by Gena P. Cook, Michael Graff, Eva Ho and Paul Zeltzer in 2008 and is headquartered in Seattle, WA. | Health Services |
ALSP Orchid Acquisition Corp. I
 ALSP Orchid Acquisition Corp. I Financial ConglomeratesFinance ALSP Orchid Acquisition Corp. I is a blank check company. It was formed for the purpose of acquiring, through a merger, capital stock exchange, asset acquisition, stock purchase or other similar business combination, one or more operating businesses. The company was founded on August 31, 2021 and is headquartered in Seattle, WA. | Finance |
- Borsa valori
- Insiders
- Bruce Carter
